Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.745 USD | +5.23% | -5.71% | -21.59% |
04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
03-26 | Replimune Group, Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.59% | 393M | |
+23.30% | 44.96B | |
+1.03% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+10.74% | 26.08B | |
-20.62% | 19.03B | |
+5.72% | 12.75B | |
+28.14% | 12.06B | |
-4.03% | 11.75B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Barclays Lowers Price Target on Replimune Group to $13 From $50, Keeps Overweight Rating